Task: Answer the multiple-choice question.
Question: Which drug exhibits a -62.970\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] COc1ccc2c(C(=O)c3ccc(C)cc3)n(CCCC(N)=O)[n+]([O-])c2c1
[b] CCCCN1C2CCCC1CC(NC(=O)c1cccc(Cl)c1)C2
[c] CCc1nc(NC(=O)c2sc(C)nc2C)sc1C(=O)OC
Answer: b. CCCCN1C2CCCC1CC(NC(=O)c1cccc(Cl)c1)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN1C2CCCC1CC(NC(=O)c1cccc(Cl)c1)C2
CCCCN1C2CCCC1CC(NC(=O)c1cccc(Cl)c1)C2
N-(9-butyl-9-azabicyclo[3.3.1]nonan-3-yl)-3-chlorobenzamide